{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:05:04Z","timestamp":1756339504107,"version":"3.44.0"},"reference-count":2,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"unspecified","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2024,10,30]]},"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1136\/bcr-2024-263019","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:50:55Z","timestamp":1732150255000},"page":"e263019","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["From multiple myeloma to therapy-related acute myeloid leukaemia"],"prefix":"10.1136","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7550-0638","authenticated-orcid":false,"given":"Radu","family":"Chiriac","sequence":"first","affiliation":[{"name":"Hematology laboratory, Hospices Civils de Lyon, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Gazzo","sequence":"additional","affiliation":[{"name":"Hematology laboratory, Hospices Civils de Lyon, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Golfier","sequence":"additional","affiliation":[{"name":"Hematology department, Hospices Civils de Lyon, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"2025082708214974000_17.11.e263019.1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00277-022-04775-1","article-title":"Therapy-related myeloid neoplasms following treatment for multiple myeloma-a single center analysis","volume":"101","author":"Boquoi","year":"2022","journal-title":"Ann Hematol"},{"key":"2025082708214974000_17.11.e263019.2","article-title":"Trends in risk for therapy-related myelodysplastic syndrome\/acute myeloid leukemia after initial chemo\/immunotherapy for common and rare lymphoid neoplasms, 2000-2018","volume":"61","author":"Morton","year":"2023","journal-title":"EClinMed"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2024-263019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:21:57Z","timestamp":1756308117000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2024-263019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":2,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,20]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1136\/bcr-2024-263019"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2024-263019","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}